REZDIFFRAREZDIFFRAREZDIFFRA

The FDA accepted REZDIFFRA dependant on evidence of efficacy from the medical trial, Trial 1, of 888 patients who had a liver biopsy exhibiting inflammation resulting from NASH with average or Sophisticated liver scarring, but not with cirrhosis of the liver.You may request your pharmacist or Health care service provider for information regarding R